Healthcare -
Biotechnology - NASDAQ - US
$ 2.475
-8.67 %
$ 176 M
Market Cap
-1.63
P/E
CCCC - SHORT-TERM DEBT
Short-term Debt CCCC - C4 Therapeutics, Inc.
5.22 M
LAST VALUE
39.86%
2 YEAR CAGR
48.04%
5 YEAR CAGR
0.00%
10 YEAR CAGR